Oobli granted FDA approval for Oubli Fruit Sweet Protein

Access more as a FoodBev subscriber

Sign up to FoodBev and unlock more insights from the international food and beverage industry. Subscribers have access to webinars, newsletters, publications and more...

Subscribe now >

Oobli granted FDA approval for Oubli Fruit Sweet Protein

Rafaela Sousa

21 March 2024

Ingredients

Oobli granted FDA approval for Oubli Fruit Sweet Protein

Oobli, a developer of sweet proteins and sugar alternatives, has received a 'No Questions' letter from the US Food and Drug Administration (FDA) for its Oubli Fruit Sweet Protein. The letter confirms Oobli's self-affirmed Generally Recognized As Safe (GRAS) status for Oubli Fruit Sweet Protein, supporting its use as a sweetener for food and beverages. Scientifically known as 'brazzein,' the protein is made via precision fermentation.

Jason Ryder, Oobli's founder and CTO, said: “Oobli is changing the future of sweetness through the use of sweet proteins as a replacement for traditional cane sugar and other alternative sweeteners like aspartame, sucralose, stevia and erythritol".

"The Oubli Fruit Sweet Protein is one of several sweet proteins that is derived from fruits primarily found in West Africa and other equatorial environments. Sweet proteins are a class of proteins that deliver a sugar-like sweetness but don't affect blood sugar, insulin or the gut microbiome.”

Ali Wing, CEO of Oobli, added: “The 'No Questions' letter from the FDA is a further testament to the strong potential that sweet proteins have to disrupt our global dependence on sugar and alternative sweeteners".

"The Oubli Fruit Sweet Protein can be safely used in various foods with support from the general scientific community and the FDA. It can replace 70% or more of sugar in most food and beverages such as sodas, teas, baked goods and more, making the opportunities to reduce our sugar consumption endless.”